A

Amylyx Pharmaceuticals
D

AMLX

5.04000
USD
-0.07
(-1.37%)
مغلق
حجم التداول
40,435
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
449,271,078
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ شهر
buy
2025-05-19 06:35
AMLX Chart
المزيد
الأخبار المقالات

العنوان: Amylyx Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.